Zomedica CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

Zomedica Corp. has issued a final reminder to its shareholders to submit their proxy votes by June 8, 2025, for the upcoming Annual Shareholder Meeting on June 10, 2025.
Zomedica Corp. has issued a reminder to its shareholders to submit their proxies by June 8, 2025, for the upcoming virtual Annual Shareholder Meeting on June 10, 2025.
Zomedica Corp. has issued a proxy statement to shareholders, encouraging votes for its upcoming virtual Annual Meeting on June 10, 2025, while highlighting recent Q1 financial results and an upcoming webinar on its PulseVet Shock Wave System.
Zomedica Corp. issues a supplement to its definitive proxy statement to correct an omission of executive compensation details for Tony Blair and Karen DeHaan-Fullerton for the year ended December 31, 2023.
A preliminary proxy statement has been filed, indicating upcoming corporate actions requiring shareholder input.
Zomedica Corp. will hold its Annual Meeting of Shareholders on June 10, 2025, to vote on director elections, auditor ratification, and executive compensation.
Zomedica Corp. will hold its annual shareholder meeting virtually on June 6, 2024, to elect directors, ratify the appointment of auditors, and approve executive compensation.
Zomedica Corp. announces its annual shareholder meeting to be held virtually on June 6, 2024, to vote on director elections, auditor ratification, and executive compensation.